(firstQuint)Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH).

 Primary: Describe the efficacy of 0.

25% and 0.

5% topical timolol maleate GFS as assessed through IH changes in volume.

 Secondary: Describe the safety and PK of topical timolol maleate GFS for treatment of IH.

.

 Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)@highlight

The purpose of this study is to assess the safety and efficacy of Timolol 0.

25% and 0.

5% doses.

